vs
Axsome Therapeutics, Inc.（AXSM）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
世纪互联的季度营收约是Axsome Therapeutics, Inc.的1.9倍（$362.7M vs $196.0M），世纪互联净利率更高（-10.7% vs -14.6%，领先3.9%），Axsome Therapeutics, Inc.自由现金流更多（$-18.7M vs $-193.1M），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs 17.4%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
AXSM vs VNET — 直观对比
营收规模更大
VNET
是对方的1.9倍
$196.0M
净利率更高
VNET
高出3.9%
-14.6%
自由现金流更多
AXSM
多$174.4M
$-193.1M
两年增速更快
AXSM
近两年复合增速
17.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $362.7M |
| 净利润 | $-28.6M | $-38.7M |
| 毛利率 | — | 20.9% |
| 营业利润率 | -13.8% | 0.5% |
| 净利率 | -14.6% | -10.7% |
| 营收同比 | 65.0% | — |
| 净利润同比 | 61.9% | — |
| 每股收益（稀释后） | $-0.55 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMVNET
| Q4 25 | $196.0M | — | ||
| Q3 25 | $171.0M | $362.7M | ||
| Q2 25 | $150.0M | — | ||
| Q1 25 | $121.5M | $309.5M | ||
| Q4 24 | $118.8M | — | ||
| Q3 24 | $104.8M | $302.2M | ||
| Q2 24 | $87.2M | $274.4M | ||
| Q1 24 | $75.0M | $262.9M |
净利润AXSMVNET
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | $-38.7M | ||
| Q2 25 | $-48.0M | — | ||
| Q1 25 | $-59.4M | $-2.4M | ||
| Q4 24 | $-74.9M | — | ||
| Q3 24 | $-64.6M | $-2.1M | ||
| Q2 24 | $-79.3M | $-1.1M | ||
| Q1 24 | $-68.4M | $-22.0M |
毛利率AXSMVNET
| Q4 25 | — | — | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 25.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 23.2% | ||
| Q2 24 | — | 21.3% | ||
| Q1 24 | — | 21.6% |
营业利润率AXSMVNET
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | 0.5% | ||
| Q2 25 | -24.5% | — | ||
| Q1 25 | -46.9% | 0.1% | ||
| Q4 24 | -61.1% | — | ||
| Q3 24 | -59.8% | 24.5% | ||
| Q2 24 | -89.5% | 0.2% | ||
| Q1 24 | -89.7% | 0.2% |
净利率AXSMVNET
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | -10.7% | ||
| Q2 25 | -32.0% | — | ||
| Q1 25 | -48.9% | -0.8% | ||
| Q4 24 | -63.1% | — | ||
| Q3 24 | -61.7% | -0.7% | ||
| Q2 24 | -91.0% | -0.4% | ||
| Q1 24 | -91.1% | -8.4% |
每股收益（稀释后）AXSMVNET
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | — | ||
| Q2 25 | $-0.97 | — | ||
| Q1 25 | $-1.22 | — | ||
| Q4 24 | $-1.54 | — | ||
| Q3 24 | $-1.34 | — | ||
| Q2 24 | $-1.67 | — | ||
| Q1 24 | $-1.44 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $492.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $88.3M | $890.8M |
| 总资产 | $689.8M | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMVNET
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | $492.1M | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $300.9M | $544.3M | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | $219.5M | ||
| Q2 24 | $315.7M | $247.2M | ||
| Q1 24 | $331.4M | $246.9M |
总债务AXSMVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AXSMVNET
| Q4 25 | $88.3M | — | ||
| Q3 25 | $73.7M | $890.8M | ||
| Q2 25 | $73.1M | — | ||
| Q1 25 | $53.2M | $927.8M | ||
| Q4 24 | $57.0M | — | ||
| Q3 24 | $92.9M | $902.9M | ||
| Q2 24 | $102.9M | $900.6M | ||
| Q1 24 | $144.0M | $895.1M |
总资产AXSMVNET
| Q4 25 | $689.8M | — | ||
| Q3 25 | $669.3M | $6.1B | ||
| Q2 25 | $639.8M | — | ||
| Q1 25 | $596.7M | $5.4B | ||
| Q4 24 | $568.5M | — | ||
| Q3 24 | $561.5M | $4.3B | ||
| Q2 24 | $548.2M | $4.0B | ||
| Q1 24 | $545.7M | $3.9B |
负债/权益比AXSMVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | $-193.1M |
| 自由现金流率自由现金流/营收 | -9.6% | -53.2% |
| 资本支出强度资本支出/营收 | 0.0% | 84.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-93.9M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流AXSMVNET
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | $113.8M | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.4M | $27.0M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.6M | $108.3M | ||
| Q2 24 | $-30.1M | $55.8M | ||
| Q1 24 | $-53.5M | $37.1M |
自由现金流AXSMVNET
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | $-193.1M | ||
| Q2 25 | $-32.4M | — | ||
| Q1 25 | $-43.7M | $-220.0M | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $-18.7M | $-95.0M | ||
| Q2 24 | $-30.2M | $-81.6M | ||
| Q1 24 | $-53.6M | $-102.2M |
自由现金流率AXSMVNET
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | -53.2% | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -36.0% | -71.1% | ||
| Q4 24 | -22.1% | — | ||
| Q3 24 | -17.9% | -31.4% | ||
| Q2 24 | -34.6% | -29.8% | ||
| Q1 24 | -71.4% | -38.9% |
资本支出强度AXSMVNET
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 84.6% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | 79.8% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | 67.3% | ||
| Q2 24 | 0.1% | 50.1% | ||
| Q1 24 | 0.1% | 53.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
